{"id":"https://openalex.org/W2005508353","doi":"https://doi.org/10.1016/j.bmcl.2010.07.004","title":"Succinic acid amides as P2\u2013P3 replacements for inhibitors of interleukin-1\u03b2 converting enzyme (ICE or caspase 1)","display_name":"Succinic acid amides as P2\u2013P3 replacements for inhibitors of interleukin-1\u03b2 converting enzyme (ICE or caspase 1)","alternate_titles":[],"publication_year":2010,"publication_date":"2010-07-09","ids":{"openalex":"https://openalex.org/W2005508353","doi":"https://doi.org/10.1016/j.bmcl.2010.07.004","mag":"2005508353","pmid":"https://pubmed.ncbi.nlm.nih.gov/20656488"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2010.07.004","doi":"https://doi.org/10.1016/j.bmcl.2010.07.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2010.07.004","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005508353"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061574500","display_name":"Paul Galatsis","orcid":"https://orcid.org/0000-0002-0505-9058","observed_orcids":["https://orcid.org/0000-0002-0505-9058"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul Galatsis","raw_affiliation_strings":["Pfizer Global R&D, Ann Arbor, MI 48105, USA. paul.galatsis@pfizer.com","Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI, 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, Ann Arbor, MI 48105, USA. paul.galatsis@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI, 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032847147","display_name":"Bradley W. Caprathe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Caprathe","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068478314","display_name":"John L. Gilmore","orcid":"https://orcid.org/0000-0002-0520-8746","observed_orcids":["https://orcid.org/0000-0002-0520-8746"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Gilmore","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006734023","display_name":"Anthony Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Thomas","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066522192","display_name":"Kristin Linn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Linn","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susan Sheehan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Sheehan","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Harter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Harter","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017662831","display_name":"Catherine R. Kostlan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Kostlan","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059514180","display_name":"Elizabeth A. Lunney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Lunney","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063593793","display_name":"Charles J. Stankovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Stankovic","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110390539","display_name":"John R. Rubin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Rubin","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035213582","display_name":"Kenneth D. Brady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019562804","display_name":"BASF (United States)","ror":"https://ror.org/002yzpx87","country_code":"US","type":"company","lineage":["https://openalex.org/I3019562804","https://openalex.org/I4210107087"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Brady","raw_affiliation_strings":["BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA","institution_ids":["https://openalex.org/I3019562804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113560677","display_name":"Hamish Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019562804","display_name":"BASF (United States)","ror":"https://ror.org/002yzpx87","country_code":"US","type":"company","lineage":["https://openalex.org/I3019562804","https://openalex.org/I4210107087"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamish Allen","raw_affiliation_strings":["BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA","institution_ids":["https://openalex.org/I3019562804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008246476","display_name":"Robert V. Talanian","orcid":"https://orcid.org/0000-0002-6221-4923","observed_orcids":["https://orcid.org/0000-0002-6221-4923"]},"institutions":[{"id":"https://openalex.org/I3019562804","display_name":"BASF (United States)","ror":"https://ror.org/002yzpx87","country_code":"US","type":"company","lineage":["https://openalex.org/I3019562804","https://openalex.org/I4210107087"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Talanian","raw_affiliation_strings":["BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BASF Bioresearch Corporation, 100 Research Drive, Worcester, MA 01605, USA","institution_ids":["https://openalex.org/I3019562804"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5061574500"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.4164,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.534414,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"20","issue":"17","first_page":"5184","last_page":"5190"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0771000012755394,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-1-beta-converting-enzyme","display_name":"interleukin-1 beta converting enzyme","score":0.8849999904632568},{"id":"https://openalex.org/keywords/caspase-1-inhibitors","display_name":"caspase-1 inhibitors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/anti-inflammatory-drug-candidates","display_name":"anti-inflammatory drug candidates","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9307660460472107},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7196680903434753},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.703064501285553},{"id":"https://openalex.org/C139964883","wikidata":"https://www.wikidata.org/wiki/Q14901964","display_name":"Caspase 1","level":4,"score":0.6427903175354004},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.6256241798400879},{"id":"https://openalex.org/C2781041046","wikidata":"https://www.wikidata.org/wiki/Q213050","display_name":"Succinic acid","level":2,"score":0.6112883687019348},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5168550610542297},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.49416425824165344},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4748825430870056},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4546944200992584},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4369225800037384},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4359247386455536},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.264736533164978},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.1313474178314209},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019802","descriptor_name":"Succinic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D061945","descriptor_name":"Caspase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2010.07.004","doi":"https://doi.org/10.1016/j.bmcl.2010.07.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2010.07.004","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:20656488","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20656488","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1967436988","https://openalex.org/W1970561974","https://openalex.org/W1975726254","https://openalex.org/W1984026160","https://openalex.org/W1988995564","https://openalex.org/W1998081672","https://openalex.org/W2003233492","https://openalex.org/W2019669854","https://openalex.org/W2043513023","https://openalex.org/W2051658957","https://openalex.org/W2059715267","https://openalex.org/W2065676276","https://openalex.org/W2068493918","https://openalex.org/W2069984043","https://openalex.org/W2087092800","https://openalex.org/W2089154951","https://openalex.org/W2089751234","https://openalex.org/W2093684206","https://openalex.org/W2107237397","https://openalex.org/W2124596356","https://openalex.org/W2154584741","https://openalex.org/W2162568391","https://openalex.org/W2162760851","https://openalex.org/W2170226518","https://openalex.org/W2477472143","https://openalex.org/W4237678934","https://openalex.org/W4296367875"],"related_works":["https://openalex.org/W2911759730","https://openalex.org/W2952372275","https://openalex.org/W2073037125","https://openalex.org/W2011684019","https://openalex.org/W1988021733","https://openalex.org/W4245981095","https://openalex.org/W2061520564","https://openalex.org/W2055823248","https://openalex.org/W2130736695","https://openalex.org/W1971366479"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005508353","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
